PPARγ pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells
Author(s) -
Mingyi Li
Publication year - 2003
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v9.i6.1220
Subject(s) - troglitazone , apoptosis , microbiology and biotechnology , cell growth , cell culture , biology , peroxisome proliferator activated receptor , blot , signal transduction , receptor , programmed cell death , chemistry , biochemistry , gene , genetics
To investigate whether troglitazone (TGZ), the peroxisome proliferator-activated receptor (PPAR) gamma ligand, can induce apoptosis and inhibit cell proliferation in human liver cancer cell line HepG2 and to explore the molecular mechanisms.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom